Literature DB >> 26740338

Cardiac autonomic neuropathy risk estimated by sudomotor function and arterial stiffness in Chinese subjects.

Q Zeng1, S-Y Dong2, M-L Wang3, F Wang1, J-M Li2, X-L Zhao4.   

Abstract

The SUDOSCAN test was recently developed to detect diabetic autonomic neuropathy early and screen for cardiac autonomic neuropathy (CAN) through assessment of sudomotor function. The aim of this study was to investigate the relationship of cardiac autonomic dysfunction estimated by the SUDOSCAN test with arterial stiffness. A total of 4019 subjects without diabetes or established cardiovascular disease were tested with SUDOSCAN, central systolic blood pressure (cSBP) and brachial-ankle pulse wave velocity (baPWV). Hands mean electrochemical skin conductance (ESC) measured by SUDOSCAN was 70±17 μS, feet mean ESC was 71±16 μS and the CAN risk score was 21±10%. The levels of cSBP and baPWV increased across quartiles of CAN risk score (P for trend <0.001 for all). In spearman correlation analyses, the CAN risk score was positively correlated with cSBP (r=0.391, P<0.001) and baPWV (r=0.305, P<0.001). In multivariable analyses, the values of cSBP and baPWV increased 0.17 mm Hg (P=0.002) and 2.01 cm per second (P=0.010), respectively, when CAN risk score increased 1%. The results were unchanged when stratified by glucose tolerance status. In conclusion, cardiac autonomic dysfunction estimated by sudomotor function was correlated with arterial stiffness independent of conventional factors and glucose tolerance status.

Entities:  

Mesh:

Year:  2016        PMID: 26740338     DOI: 10.1038/jhh.2015.126

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  24 in total

Review 1.  Nerves, fat, and insulin resistance.

Authors:  Guenther Boden; Robert D Hoeldtke
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

2.  Sudomotor function assessment as a screening tool for microvascular complications in type 2 diabetes.

Authors:  V G Eranki; R Santosh; K Rajitha; A Pillai; P Sowmya; J Dupin; J H Calvet
Journal:  Diabetes Res Clin Pract       Date:  2013-07-20       Impact factor: 5.602

3.  Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).

Authors:  Giacomo Zoppini; Vittorio Cacciatori; Daniele Raimondo; Marialuisa Gemma; Maddalena Trombetta; Marco Dauriz; Corinna Brangani; Isabella Pichiri; Carlo Negri; Vincenzo Stoico; Corinna Bergamini; Giovanni Targher; Lorenza Santi; Karl Thomaseth; Federico Bellavere; Riccardo C Bonadonna; Enzo Bonora
Journal:  Diabetes Care       Date:  2015-06-11       Impact factor: 19.112

Review 4.  Diabetic cardiac autonomic neuropathy: Do we have any treatment perspectives?

Authors:  Victoria A Serhiyenko; Alexandr A Serhiyenko
Journal:  World J Diabetes       Date:  2015-03-15

5.  Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation.

Authors:  H Gin; R Baudoin; C H Raffaitin; V Rigalleau; C Gonzalez
Journal:  Diabetes Metab       Date:  2011-06-28       Impact factor: 6.041

6.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

7.  The diagnostic utility of Sudoscan for distal symmetric peripheral neuropathy.

Authors:  A Gordon Smith; Margaret Lessard; Sandra Reyna; Mariana Doudova; J Robinson Singleton
Journal:  J Diabetes Complications       Date:  2014-03-06       Impact factor: 2.852

8.  Sympathetic regulation of vascular function in health and disease.

Authors:  Rosa M Bruno; Lorenzo Ghiadoni; Gino Seravalle; Raffaella Dell'oro; Stefano Taddei; Guido Grassi
Journal:  Front Physiol       Date:  2012-07-24       Impact factor: 4.566

9.  Cardiovascular autonomic neuropathy, HDL cholesterol, and smoking correlate with arterial stiffness markers determined 18 years later in type 1 diabetes.

Authors:  Catherine T Prince; Aaron M Secrest; Rachel H Mackey; Vincent C Arena; Lawrence A Kingsley; Trevor J Orchard
Journal:  Diabetes Care       Date:  2009-12-29       Impact factor: 17.152

10.  Association of EZSCAN values with arterial stiffness in individuals without diabetes or cardiovascular disease.

Authors:  Qiang Zeng; Sheng-Yong Dong; Man-Liu Wang; Hang Xiang; Xiao-Lan Zhao
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

View more
  6 in total

1.  Sudomotor function testing by electrochemical skin conductance: does it really measure sudomotor function?

Authors:  Sharika Rajan; Marta Campagnolo; Brian Callaghan; Christopher H Gibbons
Journal:  Clin Auton Res       Date:  2018-06-28       Impact factor: 4.435

2.  Gender-specific associations between apolipoprotein A1 and arterial stiffness in patients with nonalcoholic fatty liver disease.

Authors:  Xulong Sun; Ruifang Chen; Guangyu Yan; Zhiheng Chen; Hong Yuan; Wei Huang; Yao Lu
Journal:  PeerJ       Date:  2020-08-18       Impact factor: 2.984

3.  The Relationship between Cardiovascular Autonomic Dysfunction and Ocular Abnormality in Chinese T2DM.

Authors:  Dandan Wang; Baiyu Shen; Chunrong Wu; Yanyan Xue; Yanjun Liu
Journal:  J Diabetes Res       Date:  2017-06-01       Impact factor: 4.011

4.  SUDOSCAN, an Innovative, Simple and Non-Invasive Medical Device for Assessing Sudomotor Function.

Authors:  Dana Elena Gavan; Alexandru Gavan; Cosmina Ioana Bondor; Bogdan Florea; Frank Lee Bowling; Georgeta Victoria Inceu; Liora Colobatiu
Journal:  Sensors (Basel)       Date:  2022-10-06       Impact factor: 3.847

5.  Feasibility of combining heart rate variability and electrochemical skin conductance as screening and severity evaluation of cardiovascular autonomic neuropathy in type 2 diabetes.

Authors:  Yun-Ru Lai; Chih-Cheng Huang; Ben-Chung Cheng; Nai-Wen Tsai; Wen-Chan Chiu; Hsueh-Wen Chang; Jung-Fu Chen; Cheng-Hsien Lu
Journal:  J Diabetes Investig       Date:  2021-03-13       Impact factor: 4.232

6.  Association of serum stromal cell-derived factor 1 levels with EZSCAN score and its derived indicators in patients with type 2 diabetes.

Authors:  Wang-Shu Liu; Ling-Yan Hua; Su-Xiang Zhu; Feng Xu; Xue-Qin Wang; Chun-Feng Lu; Jian-Bin Su; Feng Qi
Journal:  Endocr Connect       Date:  2022-04-26       Impact factor: 3.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.